1ju6

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Crystal structures of four pyrrolo(2,3-d)pyrimidine-based antifolate, compounds, developed as inhibitors of thymidylate synthase (TS) in a, strategy to circumvent drug-resistance, have been determined in complexes, with their in vivo target, human thymidylate synthase, and with the, structurally best-characterized Escherichia coli enzyme, to resolutions of, 2.2-3.0 A. The 2.9 A crystal structure of a complex of human TS with one, of the inhibitors, the multi-targeted antifolate LY231514, demonstrates, that this compound induces a "closed" enzyme conformation and leads to, formation of a covalent bond between enzyme and substrate. This structure, is one of the first liganded human TS structures, and its solution was, aided by mutation to facilitate crystallization. Structures of three other, pyrrolo(2,3-d)pyrimidine-based antifolates in complex with Escherichia, coli TS confirm the orientation of this class of inhibitors in the active, site. Specific interactions between the polyglutamyl moiety and a, positively charged groove on the enzyme surface explain the marked, increase in affinity of the pyrrolo(2,3-d)pyrimidine inhibitors once they, are polyglutamylated, as mediated in vivo by the cellular enzyme folyl, polyglutamate synthetase.
+
Crystal structures of four pyrrolo(2,3-d)pyrimidine-based antifolate compounds, developed as inhibitors of thymidylate synthase (TS) in a strategy to circumvent drug-resistance, have been determined in complexes with their in vivo target, human thymidylate synthase, and with the structurally best-characterized Escherichia coli enzyme, to resolutions of 2.2-3.0 A. The 2.9 A crystal structure of a complex of human TS with one of the inhibitors, the multi-targeted antifolate LY231514, demonstrates that this compound induces a "closed" enzyme conformation and leads to formation of a covalent bond between enzyme and substrate. This structure is one of the first liganded human TS structures, and its solution was aided by mutation to facilitate crystallization. Structures of three other pyrrolo(2,3-d)pyrimidine-based antifolates in complex with Escherichia coli TS confirm the orientation of this class of inhibitors in the active site. Specific interactions between the polyglutamyl moiety and a positively charged groove on the enzyme surface explain the marked increase in affinity of the pyrrolo(2,3-d)pyrimidine inhibitors once they are polyglutamylated, as mediated in vivo by the cellular enzyme folyl polyglutamate synthetase.
==Disease==
==Disease==
Line 18: Line 18:
[[Category: Thymidylate synthase]]
[[Category: Thymidylate synthase]]
[[Category: Biermann, D.]]
[[Category: Biermann, D.]]
-
[[Category: Finer-Moore, J.S.]]
+
[[Category: Finer-Moore, J S.]]
-
[[Category: Fritz, T.A.]]
+
[[Category: Fritz, T A.]]
-
[[Category: Gates, S.B.]]
+
[[Category: Gates, S B.]]
-
[[Category: MacKellar, W.C.]]
+
[[Category: MacKellar, W C.]]
-
[[Category: Patel, V.F.]]
+
[[Category: Patel, V F.]]
-
[[Category: Sayre, P.H.]]
+
[[Category: Sayre, P H.]]
-
[[Category: Stroud, R.M.]]
+
[[Category: Stroud, R M.]]
[[Category: LYA]]
[[Category: LYA]]
[[Category: PO4]]
[[Category: PO4]]
Line 33: Line 33:
[[Category: dtmp synthesis]]
[[Category: dtmp synthesis]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:09:18 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:26:45 2008''

Revision as of 11:26, 21 February 2008


1ju6, resolution 2.89Å

Drag the structure with the mouse to rotate

Human Thymidylate Synthase Complex with dUMP and LY231514, A Pyrrolo(2,3-d)pyrimidine-based Antifolate

Contents

Overview

Crystal structures of four pyrrolo(2,3-d)pyrimidine-based antifolate compounds, developed as inhibitors of thymidylate synthase (TS) in a strategy to circumvent drug-resistance, have been determined in complexes with their in vivo target, human thymidylate synthase, and with the structurally best-characterized Escherichia coli enzyme, to resolutions of 2.2-3.0 A. The 2.9 A crystal structure of a complex of human TS with one of the inhibitors, the multi-targeted antifolate LY231514, demonstrates that this compound induces a "closed" enzyme conformation and leads to formation of a covalent bond between enzyme and substrate. This structure is one of the first liganded human TS structures, and its solution was aided by mutation to facilitate crystallization. Structures of three other pyrrolo(2,3-d)pyrimidine-based antifolates in complex with Escherichia coli TS confirm the orientation of this class of inhibitors in the active site. Specific interactions between the polyglutamyl moiety and a positively charged groove on the enzyme surface explain the marked increase in affinity of the pyrrolo(2,3-d)pyrimidine inhibitors once they are polyglutamylated, as mediated in vivo by the cellular enzyme folyl polyglutamate synthetase.

Disease

Known disease associated with this structure: Timothy syndrome OMIM:[114205]

About this Structure

1JU6 is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Thymidylate synthase, with EC number 2.1.1.45 Full crystallographic information is available from OCA.

Reference

Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases., Sayre PH, Finer-Moore JS, Fritz TA, Biermann D, Gates SB, MacKellar WC, Patel VF, Stroud RM, J Mol Biol. 2001 Nov 2;313(4):813-29. PMID:11697906

Page seeded by OCA on Thu Feb 21 13:26:45 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools